Gastrointestinal Stromal Tumor
📧 Sign up to get email alerts when something new happens for Gastrointestinal Stromal Tumor.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2017-04-27FDA Approved: STIVARGA — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA page documents Bayer's supplemental application for Stivarga (regorafenib), indicating a label change is being sought.